Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3411)
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
75,095
Price
$2.74
Total Value
$205.76K
Shares Held After
189,055
% of Holdings
39.7%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
10,900
Price
$67.84
Total Value
$739.50K
Shares Held After
7,465
% of Holdings
59.4%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
14,584
Price
$67.08
Total Value
$978.28K
Shares Held After
18,365
% of Holdings
44.3%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
30,000
Price
$2.22
Total Value
$66.70K
Shares Held After
371,702
% of Holdings
8.1%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,117
Price
$190.91
Total Value
$213.24K
Shares Held After
9,235
% of Holdings
10.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
140
Price
$334.39
Total Value
$46.81K
Shares Held After
22,129
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
942
Price
$332.48
Total Value
$313.20K
Shares Held After
22,269
% of Holdings
4.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
1,159
Price
$331.49
Total Value
$384.20K
Shares Held After
23,211
% of Holdings
4.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,259
Price
$330.73
Total Value
$747.12K
Shares Held After
24,370
% of Holdings
8.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
127
Price
$328.92
Total Value
$41.77K
Shares Held After
26,629
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
RIEDEL NORBERT G — Director
Shares
3,415
Price
$192.00
Total Value
$655.68K
Shares Held After
7,024
% of Holdings
32.7%
Larimar Therapeutics, Inc. (LRMR)
Hamilton Thomas Edward — Director
Shares
100,000
Price
$5.00
Total Value
$500.00K
Shares Held After
664,798
% of Holdings
15.0%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$509.55
Total Value
$101.91K
Shares Held After
4,845
% of Holdings
4.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
25,164
Price
$18.10
Total Value
$455.51K
Shares Held After
22,693
% of Holdings
52.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
9,406
Price
$3.01
Total Value
$28.31K
Shares Held After
173,999
% of Holdings
5.1%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — President and CFO
Shares
4,800
Price
$25.11
Total Value
$120.53K
Shares Held After
109,843
% of Holdings
4.2%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
11,787
Price
$13.14
Total Value
$154.88K
Shares Held After
1,122,183
% of Holdings
1.0%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
18,822
Price
$13.24
Total Value
$249.20K
Shares Held After
1,133,970
% of Holdings
1.6%
ARVINAS, INC. (ARVN)
Houston John G — Director
Shares
4,688
Price
$13.24
Total Value
$62.07K
Shares Held After
1,152,792
% of Holdings
0.4%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
2,000,000
Price
$5.00
Total Value
$10.00M
Shares Held After
6,207,982
% of Holdings
32.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
831,978
Price
$5.00
Total Value
$4.16M
Shares Held After
8,153,107
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,012
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,957
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
Flynn James E — Director
Shares
1,084,010
Price
$5.00
Total Value
$5.42M
Shares Held After
10,622,928
% of Holdings
10.2%
Larimar Therapeutics, Inc. (LRMR)
SHERMAN JEFFREY W — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
5,000
% of Holdings
100.0%
Larimar Therapeutics, Inc. (LRMR)
THOMAS FRANK E — Director
Shares
5,000
Price
$5.00
Total Value
$25.00K
Shares Held After
7,000
% of Holdings
71.4%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
38,000
Price
$3.44
Total Value
$130.72K
Shares Held After
56,134,097
% of Holdings
0.1%
FibroBiologics, Inc. (FBLG)
GARCIA RUBEN A — General Counsel
Shares
40,000
Price
$0.33
Total Value
$13.06K
Shares Held After
180,000
% of Holdings
22.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
HERON ELAINE J — Director
Shares
2,400
Price
$125.00
Total Value
$300.00K
Shares Held After
47,812
% of Holdings
5.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
187,171
% of Holdings
2.1%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
42,600
Price
$3.42
Total Value
$145.69K
Shares Held After
195,600
% of Holdings
21.8%
Arcellx, Inc. (ACLX)
Elghandour Rami — Director
Shares
89,916
Price
$113.92
Total Value
$10.24M
Shares Held After
276,051
% of Holdings
24.6%
Edesa Biotech, Inc. (EDSA)
Brooks Michael J — President
Shares
2,000
Price
$1.57
Total Value
$3.14K
Shares Held After
226,870
% of Holdings
0.9%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
20,571
Price
$1.58
Total Value
$32.48K
Shares Held After
615,797
% of Holdings
3.3%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,253
Price
$194.11
Total Value
$243.22K
Shares Held After
10,352
% of Holdings
10.8%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
200
Price
$103.96
Total Value
$20.79K
Shares Held After
59,634
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,602
Price
$103.41
Total Value
$269.07K
Shares Held After
59,834
% of Holdings
4.2%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,698
Price
$102.64
Total Value
$276.92K
Shares Held After
62,436
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
357
Price
$483.36
Total Value
$172.56K
Shares Held After
6,624
% of Holdings
5.1%
Bicara Therapeutics Inc. (BCAX)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
300,000
Price
$16.00
Total Value
$4.80M
Shares Held After
4,603,418
% of Holdings
6.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
197
Price
$193.60
Total Value
$38.14K
Shares Held After
58,818
% of Holdings
0.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,009
Price
$192.79
Total Value
$194.53K
Shares Held After
59,015
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,784
Price
$191.88
Total Value
$342.31K
Shares Held After
60,024
% of Holdings
2.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
549
Price
$190.80
Total Value
$104.75K
Shares Held After
61,808
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,061
Price
$190.00
Total Value
$201.59K
Shares Held After
62,357
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
3,523
Price
$193.58
Total Value
$681.99K
Shares Held After
63,418
% of Holdings
5.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
11,529
Price
$191.65
Total Value
$2.21M
Shares Held After
66,941
% of Holdings
14.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
2,916
Price
$189.81
Total Value
$553.49K
Shares Held After
68,391
% of Holdings
4.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
15,555
Price
$190.28
Total Value
$2.96M
Shares Held After
68,391
% of Holdings
18.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
875
Price
$192.07
Total Value
$168.06K
Shares Held After
56,862
% of Holdings
1.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
16,602
Price
$192.53
Total Value
$3.20M
Shares Held After
56,862
% of Holdings
22.6%
Showing 1901–1950 of 3411 transactions (page 39 of 69)